Pharmaceuticals News and Research

RSS

UTSW researchers show how vulnerable cells armor themselves against infection

Cells in some of the body's most vulnerable entry routes to bacterial infection buffer themselves when the immune system detects danger by reorganizing the cholesterol on their surfaces, a new study led by UTSW scientists suggests.

13 Apr 2020

Boehringer Ingelheim steps up to fight COVID-19 with Global Support Program

Boehringer Ingelheim has significantly stepped up its support to the fight against Covid-19. A Global Support Program has been set up to bring more financial relief, protective materials and medicine donations to healthcare institutions and communities in need around the world.

From Boehringer Ingelheim International GmbH 9 Apr 2020

What are the environmental effects of chemotherapeutic drugs?

Chemotherapeutic drugs, also known as antineoplastic agents, that are prescribed to treat a range of cancer types, enter the aquatic environment via human excretion and wastewater treatment facilities.

8 Apr 2020

Preclinical trials for two coronavirus vaccine candidates commence

Scientists at CSIRO, Australia’s national science body, and the Australian Animal Health Laboratory (AAHL) in Geelong, Victoria, have commenced preclinical trials for two novel coronavirus vaccine candidates.

7 Apr 2020

Bill and Melinda Gates fund potential vaccine against COVID-19

In a race against time, teams of scientists across the world are working towards developing an effective and safe vaccine to prevent infection from the SARS-CoV-2 virus that causes COVID-19 disease.

7 Apr 2020

Research suggests an avenue to treat, prevent genetic disorders in the womb

New research led by hearing scientists at Oregon Health & Science University suggests an avenue to treat and prevent intractable genetic disorders before birth.

6 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

COVID-19 by the numbers

Numerical data sometimes reveal facts that are otherwise concealed within an onslaught of information from an overwhelming number of sources.

2 Apr 2020

AI to predict risk of an individual patient's need for ventilator

As coronavirus patients are hospitalized, it is difficult for doctors to predict which of them will require intensive care and a respirator. Many different factors come into play, some yet to be fully understood by doctors.

2 Apr 2020

UIC participates in two clinical trials for COVID-19 treatments

The University of Illinois at Chicago is participating in two clinical trials for COVID-19 treatments.

2 Apr 2020

Global collaboration and commercialisation agreement with Axcend Corp

Microsaic Systems plc announces that it has signed integration with Axcend to integrate the compact Microsaic 4500 MiD MS with the portable Axcend Focus LC.

From Microsaic Systems 2 Apr 2020

Study looks at Russian trolls that polarize vaccination efforts

There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.

2 Apr 2020

Study: Medical product companies with female directors issue recalls more quickly

Medical product companies, such as those that make pharmaceuticals and medical devices, make recall decisions quite differently as women are added to their board of directors, according to a new study by professors at four universities, including Indiana University.

1 Apr 2020

Cobra Biologics and Karolinska Institutet join forces to develop DNA vaccine against COVID-19

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, and the Karolinska Institutet, one of the world’s leading medical universities, today announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19, as part of the OPENCORONA consortium to support global efforts tackling the pandemic.

31 Mar 2020

Neil Tween appointed as Chief Financial Officer of Owlstone Medical

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine today announces the appointment of Neil Tween as its new Chief Financial Officer.

From Owlstone Medical Ltd 31 Mar 2020

Unlocking The Power Of Expert Analytics

Malvern Panalytical and Concept Life Sciences combine experience and know-how in unique partnership

From Malvern Panalytical 31 Mar 2020

Evinacumab drug reduces cholesterol levels in patients with rare cholesterol disorder

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol to near-normal levels among patients with a rare cholesterol disorder, meeting the primary endpoint in the first randomized placebo-controlled trial of the drug, which is being presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

31 Mar 2020

Monoclonal antibody reduces LDL cholesterol in adult patients with HoFH

The cholesterol drug alirocumab reduced low-density lipoprotein (LDL) cholesterol by 35.6% compared to placebo in adult patients with homozygous familial hypercholesterolemia (HoFH), according to a phase three clinical trial presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.

30 Mar 2020

How long to a coronavirus vaccine?

The whole world is waiting for one. A vaccine is the only thing that could conceivably save the world from a horrifying cascade of deaths, other than a miracle, it seems.

29 Mar 2020

New study examines the impact of female board representation on medical product recalls

In a study published online yesterday focused on the medical products industry - which includes medical devices, pharmaceuticals and biologics - a group of researchers found that, compared to firms with all-male boards, firms with female directors announced high-severity product recalls 28 days sooner.

27 Mar 2020